COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 19, 2023 |
Nov. 16, 2021 |
Dec. 31, 2022 |
Sep. 30, 2023 |
|
| Subsidiary, Sale of Stock [Line Items] | ||||
| Offering price per share | $ 10.60 | |||
| Waived deferred underwriting fee | $ 342,975 | |||
| Accrued contingent legal costs | 2,066,035 | $ 4,522,137 | ||
| Business combination acquisition related costs | $ 7,000,000 | |||
| Retained Earnings [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Waived deferred underwriting fee | $ 6,655,361 | |||
| Underwriting Agreement [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Underwriter cash discount per unit | $ 0.20 | |||
| Payment of underwriting commissions | $ 3,999,049 | |||
| Deferred fee | $ 0.35 | |||
| Deferred underwriting fee | $ 6,998,336 | |||
| Over-Allotment Option [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Purchase of additional shares | 2,495,246 | 2,625,000 | ||
| Offering price per share | $ 10.00 | |||
| Proceeds from shares | $ 24,952,460 | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. No definition available.
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|